The Inflation Reduction Act could lead to broader changes in drug development and pricing.
Healthcare affordability is an issue for many employees, especially with inflation stressing household budgets. Employers are trying to keep more money in employees’ paychecks and remove cost barriers when care is needed.
Despite a slowdown in deal making, pharmaceuticals and healthtech continue to get attention from investors.
Commercial group lines of business have experienced flat growth in recent years. Health plans need to strengthen their fundamentals and tightly coordinate operations to achieve meaningful top line growth.
The best way to start fighting burnout is to build trust and open communication so you can truly understand the factors that are contributing to it.
Interoperability standards and consumer protection hold the key to the growth of these virtual worlds.
What the $3.9 billion deal could mean for the industry
Insights on potential near-term and long-term impact for consumers, employers, and incumbents.
The digital model transition has advanced since the pandemic, directing millions of people online for everything from payments to performing their jobs.
The record pace of investment in healthcare spurred a lot of innovation, but now it’s time to tackle more complex problems.
The current economic climate opens the door for investors and innovators to rethink partnerships and ways to access capital.